SPOTLIGHT -
Pediatric psoriasis treatment challenges
Investigators have found that there are limited options for treating pediatric psoriasis.
FDA approves Xofluza for treatment of influenza in children 5 years and older
Xofluza is now the first single-dose oral medication for influenza approved for children aged less than 12 years.
Antimicrobial Stewardship Programs decrease antibiotic initiation at birth
ASP treatment lowered the presence of sepsis risk factors in preterm infants.
Low birth weight associated with attention problems in children
Investigators found that symptoms of attention-deficit/hyperactivity disorder were more often seen in children with a lower birth weight.
Possible mediators for perioperative respiratory adverse events discussed
Investigators compared the effects of midazolam, dexmedetomidine, and saline control on the appearance of perioperative respiratory adverse events in children.
Pharmacological treatments found effective against substance use disorders
Treatments for ADHD proved to be the most effective in reducing the risks of developing substance use disorders.
Less invasive surfactant administration reduces adverse outcomes in infants
A study by the German Neonatal Network associated application of less invasive surfactant administration with fewer complications and lower mortality rates.
Few pediatric devices were approved after a clinical trial involving children
Many devices approved for pediatric use were not tested in a clinical trial involving children.
Parents express low confidence in pediatric COVID-19 vaccine
Only one-fifth of parents in a recent survey indicated intentions of getting their child the vaccine within 3 months of eligibility.
Child death by gun violence increased during COVID-19 pandemic
Studies indicate that child deaths by gun violence were comparable to those by COVID-19.
Smoking during pregnancy associated with smaller brain volume in child
Smoking tobacco should cease during pregnancy, according to The Journal of the American Medical Association.
AAP announces revisions to clinical guidelines for hyperbilirubinemia treatment in infants
Hyperbilirubinemia can lead to brain complications in rare instances, which the guidelines work to prevent.
Amid decline in immunizations, AAP urges parents to keep up to date with child vaccinations
As immunization rates fall in children, the American Academy of Pediatrics recommends a checkup with physicians.
Managed care plans for children should follow guiding principles to be most efficient
Health care is more effective when developed to support specific needs of children.
COVID-19 vaccination recommended for US children 5 to 11 years, despite adverse events
The American Academy of Pediatrics (AAP) recommends children aged 5 to 11 receive the BNT-162b2 vaccination.
